Israel vs Republic of Moldova: Tuberculosis treatment success rate by type
Israel
85
in 2023
Republic of Moldova
85
in 2023
Israel rank
83rd
Republic of Moldova rank
83rd
Tuberculosis treatment success rate by type over time
- Israel
- Republic of Moldova
How they compare
Israel currently reports 85 against 85 in Republic of Moldova, a difference of 0.
The two have swapped places 5 times across 25 shared years of data; in 1999 it was Israel ahead.
Israel ranks 83rd and Republic of Moldova ranks 83rd of 194 countries.
Israel has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Israel | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 85 | 60 | 25 | Israel |
| 2000s | 85.8 | 67.7 | 18.1 | Israel |
| 2010s | 82.7 | 78.8 | 3.9 | Israel |
| 2020s | 83.25 | 82.25 | 1 | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Israel or Republic of Moldova?
- Israel, at 85 against 85 in Republic of Moldova as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Israel and Republic of Moldova?
- 0, with Israel ahead.
- How many years of comparable data are there for Israel and Republic of Moldova?
- 25 years are reported by both, from 1999 to 2023.
- How do Israel and Republic of Moldova rank globally for tuberculosis treatment success rate by type?
- Israel ranks 83rd and Republic of Moldova ranks 83rd of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.